60° Pharmaceuticals
1025 Connecticut Avenue NW
Suite 1000
Washington
District of Columbia
20036
United States
Tel: 202-327-5422
About 60° Pharmaceuticals
60P, founded in 2010, focuses on discovering, developing and distributing new medicines for treatment and prevention of tropical diseases, including malaria and dengue.
YEAR FOUNDED:
2010
LEADERSHIP:
Founder and CEO: Geoffrey Dow
CFO: Tyrone Miller
CMO: Bryan Smith
CLINICAL TRIAL:
3 articles about 60° Pharmaceuticals
-
60° Pharmaceuticals (60P) announced today the Food and Drug Administration (FDA) approval of ARAKODA™ (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older.
-
The company submitted the NDA in December.
-
60° Pharma Submits NDA to U.S. FDA for Antimalarial Drug Tafenoquine
12/18/2017
60 Degrees Pharma as submitted a NDA to the FDA for the use of Tafenoquine to prevent malaria in adults traveling to areas where malaria is prevalent.